Literature DB >> 33968488

Pembrolizumab-Induced CNS Vasculitis: Neurologic Adverse Events Due to Checkpoint Inhibitors.

Jenny Feng1, Lindsay Ross1, Daniel Ontaneda1.   

Abstract

Entities:  

Year:  2021        PMID： 33968488      PMCID： PMC8101305          DOI： 10.1212/CPJ.0000000000000768

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

Review 1.  Immune checkpoint dysfunction in large and medium vessel vasculitis.

Authors:  Ryu Watanabe; Hui Zhang; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

Review 2.  The blockade of immune checkpoints in cancer immunotherapy.

Authors:  Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

3.  Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  J B A G Haanen; F Carbonnel; C Robert; K M Kerr; S Peters; J Larkin; K Jordan
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

4.  Vasculitis associated with immune checkpoint inhibitors-a systematic review.

Authors:  Anisha Daxini; Keri Cronin; Antoine G Sreih
Journal:  Clin Rheumatol       Date:  2018-06-19       Impact factor: 2.980

5.  Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma.

Authors:  Bing Liao; Sheetal Shroff; Carlos Kamiya-Matsuoka; Sudhakar Tummala
Journal:  Neuro Oncol       Date:  2014-01-30       Impact factor: 12.300

Review 6.  Neurological toxicities associated with immune-checkpoint inhibitors.

Authors:  Mehdi Touat; Daniel Talmasov; Damien Ricard; Dimitri Psimaras
Journal:  Curr Opin Neurol       Date:  2017-12       Impact factor: 5.710

Review 7.  Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.

Authors:  Celine Boutros; Ahmad Tarhini; Emilie Routier; Olivier Lambotte; Francois Leroy Ladurie; Franck Carbonnel; Hassane Izzeddine; Aurelien Marabelle; Stephane Champiat; Armandine Berdelou; Emilie Lanoy; Matthieu Texier; Cristina Libenciuc; Alexander M M Eggermont; Jean-Charles Soria; Christine Mateus; Caroline Robert
Journal:  Nat Rev Clin Oncol       Date:  2016-05-04       Impact factor: 66.675
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.